China Resources Medical Holdings Company Limited provided consolidated financial guidance for the fiscal year ended December 31, 2022. The Group expects that the profit for the year attributable to owners of the parent company of the Group as contained in the consolidated financial statements for the Reporting Period would record a decrease of approximately 65% as compared with the corresponding period of 2021.
China Resources Medical Holdings Company Limited
Equities
1515
KYG2133W1087
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.13 HKD | +3.51% | +11.02% | -14.32% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.32% | 684M | |
-20.16% | 16.21B | |
+4.50% | 12.44B | |
+3.98% | 11.58B | |
+9.72% | 10.79B | |
-2.19% | 7.68B | |
+18.43% | 7.2B | |
+4.49% | 6.67B | |
+50.89% | 4.66B | |
-5.12% | 4.25B |
- Stock Market
- Equities
- 1515 Stock
- News China Resources Medical Holdings Company Limited
- China Resources Medical Holdings Company Limited Provides Consolidated Financial Guidance for the Fiscal Year Ended December 31, 2022